Cargando…

Use of sodium‐glucose co‐transporter‐2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations

Early onset of type 2 diabetes and a high prevalence of co‐morbidities predispose the Asian population to a high risk for, and rapid progression of, diabetic kidney disease (DKD). Apart from renin‐angiotensin system inhibitors, sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors have been shown to d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khoo, Chin Meng, Deerochanawong, Chaicharn, Chan, Siew Pheng, Matawaran, Bien, Sheu, Wayne Huey‐Herng, Chan, Juliana, Mithal, Ambrish, Luk, Andrea, Suastika, Ketut, Yoon, Kun‐Ho, Ji, Linong, Man, Nguyen Huu, Pollock, Carol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839543/ https://www.ncbi.nlm.nih.gov/pubmed/33155749 http://dx.doi.org/10.1111/dom.14251

Ejemplares similares

Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations
por: Sheu, Wayne Huey-Herng, et al.
Publicado: (2020)

Use of sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations
por: Deerochanawong, Chaicharn, et al.
Publicado: (2019)

Consensus Recommendations by the Asian Pacific Society of Cardiology: Optimising Cardiovascular Outcomes in Patients with Type 2 Diabetes
por: Tan, Jack Wei Chieh, et al.
Publicado: (2021)

Use of basal insulin in the management of adults with type 2 diabetes: An Asia‐Pacific evidence‐based clinical practice guideline
por: Ji, Linong, et al.
Publicado: (2023)

Device-supported automated basal insulin titration in adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
por: Luo, Yingying, et al.
Publicado: (2023)

Real‐world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register
por: Lim, Lee‐Ling, et al.
Publicado: (2022)

Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East
por: Alshamiri, Mostafa, et al.
Publicado: (2018)

Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta‐analysis
por: Luo, Yingying, et al.
Publicado: (2023)

An Asian viewpoint on the use of vitamin D and calcium in osteoporosis treatment: Physician and patient attitudes and beliefs
por: Chan, Siew Pheng, et al.
Publicado: (2010)

Choice of Insulin in Type 2 Diabetes: A Southeast Asian Perspective
por: Kalra, Sanjay, et al.
Publicado: (2017)

AFES A.S.-O.N.E.: ASEAN Survey Of Needs in Endocrinology in the Time of the COVID-19 Pandemic
por: Jasul, Gabriel, et al.
Publicado: (2020)

Perceptions of Painful Diabetic Peripheral Neuropathy in South-East Asia: Results from Patient and Physician Surveys
por: Malik, Rayaz A., et al.
Publicado: (2017)

Comparison of efficacy and safety of two starting insulin regimens in non-Asian, Asian Indian, and East Asian patients with type 2 diabetes: a post hoc analysis of the PARADIGM study
por: Ji, Linong, et al.
Publicado: (2016)

Efficacy and safety of premixed insulin analogs in Asian patients with type 2 diabetes: A systematic review
por: Sheu, Wayne H‐H, et al.
Publicado: (2017)

Optimizing Glycemic Control Through Titration of Insulin Glargine 100 U/mL: A Review of Current and Future Approaches with a Focus on Asian Populations
por: Deerochanawong, Chaicharn, et al.
Publicado: (2017)

Meta‐analysis and critical review on the efficacy and safety of alpha‐glucosidase inhibitors in Asian and non‐Asian populations
por: Gao, Xueying, et al.
Publicado: (2017)

Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective
por: Ji, Linong, et al.
Publicado: (2020)

Electrocardiographic and Echocardiographic Insights From a Prospective Registry of Asian Elite Athletes
por: Yeo, Tee Joo, et al.
Publicado: (2022)

No disparity of the efficacy and all‐cause mortality between Asian and non‐Asian type 2 diabetes patients with sodium–glucose cotransporter 2 inhibitors treatment: A meta‐analysis
por: Cai, Xiaoling, et al.
Publicado: (2017)

Comparisons of the Efficacy of Alpha Glucosidase Inhibitors on Type 2 Diabetes Patients between Asian and Caucasian
por: Cai, Xiaoling, et al.
Publicado: (2013)

Diabetes management in Thailand: a literature review of the burden, costs, and outcomes
por: Deerochanawong, Chaicharn, et al.
Publicado: (2013)

An expert consensus for the management of chronic hepatitis B in Asian Americans
por: Tong, M. J., et al.
Publicado: (2018)

Optimal Use of Perampanel in Asian Patients with Epilepsy: Expert Opinion
por: Chinvarun, Yotin, et al.
Publicado: (2021)

Basal Insulin Dose Titration for Glycemic Control in Patients With Type 2 Diabetes Mellitus in Thailand: Results of the REWARDS Real-World Study
por: Deerochanawong, Chaicharn, et al.
Publicado: (2020)

The new Asian architecture : vernacular traditions and contemporary style /
por: Lim, William Siew Wai, 1932-
Publicado: (1998)

Association of genetic polymorphisms with acute kidney injury after cardiac surgery in a Southeast Asian population
por: Saw, Kah Ming Eddy, et al.
Publicado: (2019)

Optimal Use of Perampanel in Elderly Asian Patients with Epilepsy: Expert Opinion
por: Huang, Chin-Wei, et al.
Publicado: (2022)

Statin Intolerance—An Asian Perspective
por: Tomlinson, Brian, et al.
Publicado: (2020)

South Asian Working Action Group on SARCOpenia (SWAG-SARCO) – A consensus document
por: Dhar, Minakshi, et al.
Publicado: (2022)

The low level of glucagon-like peptide-1 (glp-1) is a risk factor of type 2 diabetes mellitus
por: Lastya, Agus, et al.
Publicado: (2014)

Cost–benefit comparison of liraglutide and sitagliptin in the treatment of type 2 diabetes in Thailand
por: Deerochanawong, Chaicharn, et al.
Publicado: (2019)

Real-world management of abnormal scarring using topical silicone gel: expert consensus and case series from the Asian SCARS Expert Group
por: Yang, Xiaonan, et al.
Publicado: (2023)

Predictors of Poor Glycemic Control and Increased Glucose Variability Among Admitted Moderate to Critical COVID-19 Patients with Type 2 Diabetes Mellitus: A Single Center Cross-sectional Study*
por: Martin Bagos, John Paul, et al.
Publicado: (2023)

Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment
por: Mohan, Viswanathan, et al.
Publicado: (2019)

Cognitive Dysfunction in Asian Patients with Depression (CogDAD): A Cross-Sectional Study
por: Manit, Srisurapanont, et al.
Publicado: (2017)

Cognitive Dysfunction in Asian Patients with Depression (CogDAD): A Cross-Sectional Study
por: Manit, Srisurapanont, et al.
Publicado: (2017)

National Variations in Comorbidities, Glycosylated Hemoglobin Reduction, and Insulin Dosage in Asian Patients with Type 2 Diabetes: The FINE-Asia Registry
por: Ji, Linong, et al.
Publicado: (2015)

Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting
por: Kaur, Parjeet, et al.
Publicado: (2016)

A multi-staged approach to the reconstruction of a burnt Asian face
por: Joethy, Janna, et al.
Publicado: (2011)

Vitamin D in COVID - 19: Dousing the fire or averting the storm? – A perspective from the Asia-Pacific
por: Chandran, Manju, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uirnpj51qqh03ns8482rovmo0n